74 related articles for article (PubMed ID: 2037266)
1. Antiestrogenic effect of gestrinone as an inhibitor of [3H]-estradiol binding to nuclear type II sites.
Ohno Y; Kitagawa I; Tamura H; Hosoda S; Yamashita S; Honjo H; Okada H
Gynecol Obstet Invest; 1991; 31(2):97-101. PubMed ID: 2037266
[TBL] [Abstract][Full Text] [Related]
2. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
Markaverich BM; Williams M; Upchurch S; Clark JH
Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
[TBL] [Abstract][Full Text] [Related]
4. Tissue and species specificity of unmasked nuclear acceptor sites for the estrogen receptor of Squalus testes.
Ruh MF; Singh RK; Mak P; Callard GV
Endocrinology; 1986 Feb; 118(2):811-8. PubMed ID: 3943492
[TBL] [Abstract][Full Text] [Related]
5. Characterization of membrane estrogen binding proteins from rabbit uterus.
Monje P; Boland R
Mol Cell Endocrinol; 1999 Jan; 147(1-2):75-84. PubMed ID: 10195694
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a unique population of unfilled estrogen-binding sites associated with the nuclear fraction of immature rat uteri.
Carlson RA; Gorski J
Endocrinology; 1980 Jun; 106(6):1776-85. PubMed ID: 7371593
[TBL] [Abstract][Full Text] [Related]
7. CDRI-85/287: studies on competition to estrogen binding sites in the immature rat uterus.
Sreenivasulu S; Dwivedi A; Singh MM; Setty BS; Kamboj VP
Indian J Exp Biol; 1992 Dec; 30(12):1115-7. PubMed ID: 1294475
[TBL] [Abstract][Full Text] [Related]
8. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
Markaverich BM; Roberts RR; Alejandro M; Clark JH
Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
[TBL] [Abstract][Full Text] [Related]
9. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen.
Katzenellenbogen BS; Ferguson ER
Endocrinology; 1975 Jul; 97(1):1-12. PubMed ID: 166821
[TBL] [Abstract][Full Text] [Related]
10. Effects of salt extraction on the quantitation of nuclear estrogen receptors: interference by secondary estrogen binding sites.
Markaverich BM; Upchurch S; Clark JH
J Recept Res; 1980; 1(3):415-38. PubMed ID: 7299739
[TBL] [Abstract][Full Text] [Related]
11. Progesterone action in hamster uterus: rapid inhibition of 3H-estradiol retention by the nuclear fraction.
Evans RW; Leavitt WW
Endocrinology; 1980 Oct; 107(4):1261-3. PubMed ID: 7408773
[TBL] [Abstract][Full Text] [Related]
12. Estradiol-stimulated increases in uterine eosinophils and nuclear type II estrogen-binding sites are prevented by pertussis toxin.
Lyttle CR; Teuscher C; Medlock KL; Sheehan DM
Endocrinology; 1989 Nov; 125(5):2773-9. PubMed ID: 2792007
[TBL] [Abstract][Full Text] [Related]
13. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
Markaverich BM; Roberts RR; Alejandro MA; Clark JH
Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
[TBL] [Abstract][Full Text] [Related]
14. Analysis of binding of [3H]Estradiol to the cytosol fraction of rat pancreas: comparison with sites in the cytosol of uterus.
Boctor AM; Band P; Grossman A
Endocrinology; 1983 Aug; 113(2):453-62. PubMed ID: 6872936
[TBL] [Abstract][Full Text] [Related]
15. Rationale for frequency and dose of administration in gestrinone therapy for pelvic endometriosis in the experimental model of rabbit uterus.
Tamaya T; Wada K; Imai A; Mori H; Ban H
Gen Pharmacol; 1991; 22(3):505-10. PubMed ID: 1869024
[TBL] [Abstract][Full Text] [Related]
16. Effects of danazol and medroxyprogesterone acetate on estrogen-(estradiol and estriol) specific binding sites in rabbit uterus.
Misao R; Nishigaki M; Hori M; Ichigo S; Fujimoto J; Tamaya T
Gynecol Endocrinol; 1995 Mar; 9(1):29-35. PubMed ID: 7793297
[TBL] [Abstract][Full Text] [Related]
17. Effects of tamoxifen and estradiol on estrogen binding sites in the urogenital tract: an experimental study in the rabbit.
Iosif CS; al-Hijji J; Samsioe G
Gynecol Endocrinol; 2002 Oct; 16(5):379-83. PubMed ID: 12587532
[TBL] [Abstract][Full Text] [Related]
18. Interaction of estradiol and estriol with uterine estrogen receptor in vivo and in excised uteri or cell suspensions at 37 C: noncooperative estradiol binding and absence of estriol inhibition of estradiol-induced receptor activation and transformation.
Müller RE; Traish AM; Wotiz HH
Endocrinology; 1985 Nov; 117(5):1839-47. PubMed ID: 4042965
[TBL] [Abstract][Full Text] [Related]
19. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J
Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and antiestrogen binding to different forms of the molybdate-stabilized estrogen receptor.
Ruh MF; Brzyski RG; Strange L; Ruh TS
Endocrinology; 1983 Jun; 112(6):2203-5. PubMed ID: 6851947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
